Notice Requirements for Fertility Excepted Benefits (CMS-10947)
New collection (Request for a new OMB Control Number)
No
Regular
05/13/2026
table that charts list comparision
Requested
Previously Approved
36 Months From Approved
7,630,891
0
541
0
0
0
Section 2791(c)(2) of the Public Health Service Act (PHS Act), section 733(c)(2) of the Employee Retirement Income Security Act (ERISA), and section 9832(c)(2) of the Internal Revenue Code (Code) establishing four statutory categories of "excepted benefits" that are generally exempt from the health reform requirements added to those laws by the Health Insurance Portability and Accountability Act (HIPAA), the Patient Protection and Affordable Care Act (ACA), the No Surprises Act, and certain other federal laws specifically related to group health plans and group and individual health insurance coverage. On February 18, 2025, President Trump issued Executive Order 14216, "Expanding Access to In Vitro Fertilization," which instructs the Departments to provide support, awareness, and access to affordable fertility treatments, including reliable access to in vitro fertilization (IVF) treatment, by easing unnecessary statutory or regulatory burdens to make IVF treatment drastically more affordable. In the proposed rule "Excepted Fertility Benefits" (the proposed rule), the Departments propose to add new paragraph (c)(3)(ix) of 26 CFR 54.9831-1 and 29 CFR 2590.732, and new paragraph (b)(3)(ix) of 45 CFR 146.145 to establish fertility benefits as a new category of limited excepted benefits. The proposed rule would require that plans or issuers offering excepted fertility benefits provide written notice to plan participants and beneficiaries that includes a description of the coverage, including a summary of benefits and limitations of the coverage, including the lifetime dollar limit established by the plan or issuer that complies with the maximum lifetime dollar limit described in proposed paragraph (c)(3)(ix)(B) (or paragraph (b)(3)(ix)(B), as applicable),information on how to identify and utilize a network provider, if applicable, and how to submit a claim for reimbursement, including whether the benefit utilizes the same claims procedure as for the sponsorâs other group health plans. This notice requirement ensures that participants and beneficiaries are fully informed about the availability and requirements of their excepted fertility benefits coverage.
EO: EO 14216 Name/Subject of EO: Expanding Access to In Vitro Fertilization
PL:
Pub.L. 111 - 148 2791(c)(2)(C)
Name of Law: Patient Protection and Affordable Care Act â Excepted Benefits
EO: EO 14216 Name/Subject of EO: Expanding Access to In Vitro Fertilization
PL: Pub.L. 111 - 148 2791(c)(2)(C) Name of Law: Patient Protection and Affordable Care Act â Excepted Benefits
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.